1981Archives of Internal MedicineRequires access

An integrated approach to the study of chemically reactive metabolites of acetaminophen

James R. Gillette

Open publisher page 21 citations

Abstract

I have examined in mice the kinetics of covalent binding of a metabolite of acetaminophen, as well as the binding to target tissue (and hence toxic reactions). At low doses, the chemically reactive metabolite seems to be converted to a glutathione conjugate that is ultimately excreted as a mercapturic acid. High acetaminophen doses that deplete available glutathione in the liver lead to toxic reactions. Manipulation of the system with agents that affect either glutathione availability or activity of the operative enzyme system has suggested that a chemically reactive acetaminophen metabolite is the active agent in hepatotoxic reactions from the drug. The chemically reactive intermediate seems to be short lived; it reacts with glutathione and is easily reduced by ascorbic acid. Acetylcysteine prevents liver necrosis caused by acetaminophen, and some possible mechanisms are discussed.

About this research paper

What this paper is about

I have examined in mice the kinetics of covalent binding of a metabolite of acetaminophen, as well as the binding to target tissue (and hence toxic reactions). At low doses, the chemically reactive metabolite seems to be converted to a glutathione conjugate that is ultimately excreted as a mercapturic acid. High acetaminophen doses that deplete available glutathione in the liver lead to toxic reactions. Manipulation of the system with agents that affect either glutathione availability or activity of the operative enzyme system has suggested that a chemically reactive acetaminophen metabolite is the active agent in hepatotoxic reactions from the drug. The chemically reactive intermediate seems to be short lived; it reacts with glutathione and is easily reduced by ascorbic acid. Acetylcysteine prevents liver necrosis caused by acetaminophen, and some possible mechanisms are discussed.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

I have examined in mice the kinetics of covalent binding of a metabolite of acetaminophen, as well as the binding to target tissue (and hence toxic reactions). At low doses, the chemically reactive metabolite seems to be converted to a glutathione conjugate that is ultimately excreted as a mercapturic acid. High acetaminophen doses that deplete available glutathione in the liver lead to toxic reactions. Manipulation of the system with agents that affect either glutathione availability or activity of the operative enzyme system has suggested that a chemically reactive acetaminophen metabolite is the active agent in hepatotoxic reactions from the drug. The chemically reactive intermediate seems to be short lived; it reacts with glutathione and is easily reduced by ascorbic acid. Acetylcysteine prevents liver necrosis caused by acetaminophen, and some possible mechanisms are discussed.

Key concepts: Acetaminophen, Glutathione, Metabolite, Chemistry, Mercapturic acid, Ascorbic acid, Antioxidant, Cysteine

Related papers

Back to paper searchBrowse research topicsOriginal source
An integrated approach to the study of chemically reactive metabolites of acetaminophen — Research Paper | ScholarLens